InvestorsHub Logo
Followers 6
Posts 491
Boards Moderated 0
Alias Born 03/16/2017

Re: None

Friday, 08/20/2021 4:12:06 PM

Friday, August 20, 2021 4:12:06 PM

Post# of 118363


3 Reasons $RGBP Could Be Sold For CASH$$

1) The Company is Down, But Not Out.

2) The Science is MRNA Blockbuster But Bank Account isn’t.

3) Dr Koos is near the End of a long Career.

Thanks to OTCShotcaller Here's Reason #4

#4- It's going to take hundreds of millions of dollars to put the re-activated Patents into FDA Approved Clinical Trials.

Here's a link that provides an estimate for this.

https://www.jhsph.edu/news/news-releases/2018/cost-of-clinical-trials-for-new-drug-FDA-approval-are-fraction-of-total-tab.html

The average or "median" cost in 2015-2016 was $16 Million per clinical trial. Today it would be much higher.

Also, this article points out that for clinical trials that involve examining "a drug's ability to prevent a clinically meaningful outcome..", the median cost is much higher, i.e. $65 Million per trial, and again that was back in 2015-2016.

So yes as I said, to put those re-activated Patents into clinical trials is going to cost a absolute FORTUNE....ALL CASH!!

Big Pharma Buy Out is the only thing that makes sense, IMO.

Opinion Only..

Just My 2 Bits The truth is incontrovertible. Malice may attack it,
ignorance may deride it, but in the end, there it is. Do Your Own
DD Do not take my investing advice.